Patents by Inventor Michael John Rogers

Michael John Rogers has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110076274
    Abstract: The present inventors demonstrate that the G-protein coupled receptor 55 (GPR55) is highly expressed in human aggressive breast cancer cells, and that the expression level may be correlated with the invasiveness and metastatic potential of these cells (for example metastasis to bone). In various aspects of the invention there are disclosed diagnostic tools or biomarkers that relate to the metastatic profile of breast cancer tumours. The invention also relates to pharmacological agents targeting this receptor for the purposes of inhibiting progression and spread of breast cancer.
    Type: Application
    Filed: May 13, 2009
    Publication date: March 31, 2011
    Inventors: Ruth Alexandra Ross, Michael John Rogers, Lesley Ann Ford, Anke Jozefien Roelofs
  • Publication number: 20020035058
    Abstract: Methods of treatment and prophylaxis of various diseases and disorders, and in particular diseases and disorders of lipid and bone metabolism, involving the administration of prenyl transferase (farnesyl pyrophosphate synthase) and/or isopentenyl pyrophosphate isomerase inhibitor compounds are disclosed.
    Type: Application
    Filed: September 10, 2001
    Publication date: March 21, 2002
    Applicant: The University of Sheffield
    Inventors: Richard John Brown, Donald Jeremy Watts, Robert Graham Goodwin Russell, Michael John Rogers